Burnham Institute for Medical Research Advances Biomarker Research for Major Human Malignancies Using Aperio Digital Pathology Platform

VISTA, Calif.--(BUSINESS WIRE)--Aperio Technologies, Inc., the leading provider of digital pathology systems and services for the healthcare and life sciences industry, has been an ongoing collaborator with Burnham Institute for Medical Research (Burnham) to utilize Aperio’s award-winning ScanScope® slide scanning system and quantitative immunohistochemistry tools to assist in the validation and clinical translation of Burnham’s cancer biomarkers. Aperio’s digital pathology platform provides pathologists with global, Internet-secure access to digital slide images and related information from anywhere, anytime.